What are the uremic symptoms associated with chronic kidney disease (CKD)?

Uremic Symptoms of Chronic Kidney Disease

Uremic symptoms in CKD represent a nonspecific constellation of signs and symptoms that occur when kidney function deteriorates, and these symptoms should guide clinical decision-making more than GFR alone when considering dialysis initiation. 1

Core Uremic Symptoms and Signs

The KDOQI guidelines 1 specifically identify the following uremic manifestations:

Neurological Symptoms

• Seizures or changes in seizure threshold
• Somnolence (excessive sleepiness)
• Cognitive deterioration and decreased mental acuity 2, 3
• Asterixis (flapping tremor)
• Peripheral neuropathy with paresthesias (numbness/tingling)
• Myoclonus
• Restless leg syndrome 3, 4

Gastrointestinal Symptoms

• Nausea and vomiting
• Reduced appetite (anorexia)
• Hiccups
• Ammonia taste and breath 5

Metabolic and Nutritional Signs

• Protein-energy wasting
• Involuntary weight loss
• Insulin resistance
• Heightened catabolism
• Reduced core body temperature 1

Cardiovascular and Respiratory

• Serositis (pleuritis, pericarditis)
• Congestive heart failure 2
• Shortness of breath 6

Other Manifestations

• Pruritus (itching) - one of the most common symptoms 7, 6, 8
• Fatigue/lethargy - the most frequently reported symptom 7, 6, 8
• Platelet dysfunction with bleeding tendency
• Amenorrhea (in women)
• Sexual dysfunction 6
• Pain (including muscle cramps, chest pain, abdominal pain) 7, 6

Critical Clinical Considerations

Symptom Nonspecificity

A major pitfall is that uremic symptoms are inherently nonspecific and can have multiple other causes. 1 The KDOQI guidelines strongly emphasize that providers must be diligent in searching for reversible causes before attributing symptoms to uremia, especially in:

• Elderly patients
• Those on polypharmacy
• Patients with multiple comorbidities 1

Subtle Presentation

Many patients adapt to declining kidney function gradually, experiencing a slow decline in well-being without discrete uremic events. 1 They may:

• Adapt to lower levels of functioning without clearly expressing symptoms
• Reduce dietary intake unconsciously
• Lose weight without acknowledging uremic manifestations
• Lower their activity levels imperceptibly

Assessment Approach

The 2024 KDIGO guidelines 9 recommend:

• Ask about uremic symptoms at each consultation using a standardized validated assessment tool
• Focus on reduced appetite, nausea, and fatigue/lethargy levels
• Screen patients with CKD G4-G5 twice annually for malnutrition using validated tools

Symptom Clusters

Recent research 7, 6, 8 demonstrates that uremic symptoms rarely occur in isolation but rather present in clusters, with prevalence ranging from 22% to 55% depending on the specific symptom. The most common symptoms identified across studies are:

1. Fatigue or lack of energy (most prevalent)
2. Pruritus
3. Pain
4. Drowsiness
5. Nausea

Important Exclusions

Note that while anemia and hyperparathyroidism are part of the uremic milieu, they are not included in the classic uremic symptom list because they result from specific hormonal deficits or excesses rather than direct uremic toxicity. 1

Clinical Decision-Making

The decision to initiate kidney replacement therapy should be based on uremic symptoms and signs rather than GFR level alone. 1, 10 The guidelines explicitly state that:

• eGFR alone is insufficient for dialysis timing decisions due to measurement imprecision
• Symptoms should be evaluated in context of patient goals and preferences
• There is no perfect GFR threshold applicable to all patients
• The purpose of dialysis is "promotion of living," not solely prolongation of life 1

The Work Group acknowledges this remains within the "art" of medicine, requiring individualized assessment rather than prescriptive thresholds 1.